Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on June 14, 2026

Jun. 14, 2026

KFSH Space Medicine Study Ranks Among Top 5% Globally on Altmetric

Indeterminate EIN Presswire

14 hours ago

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

Indeterminate GlobeNewswire

15 hours ago

Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026

Indeterminate GlobeNewswire

17 hours ago

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control

Indeterminate GlobeNewswire

Jun. 14, 2026

Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading

Indeterminate GlobeNewswire

Jun. 14, 2026

Stake Launches its Referral Code SHIMA – 200% Bonus and 5% Cashback for New Users in 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph

Indeterminate GlobeNewswire

Jun. 14, 2026

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

Jun. 14, 2026

Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)

Indeterminate GlobeNewswire

Jun. 14, 2026

Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day

Indeterminate GlobeNewswire

Jun. 14, 2026

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Indeterminate GlobeNewswire

Jun. 14, 2026

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

Indeterminate GlobeNewswire

Jun. 14, 2026

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Indeterminate GlobeNewswire

Jun. 14, 2026

KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

Das KFSH stellt auf der HLTH Europe 2026 menschenzentrierte KI als Weg zu einer besseren Versorgung in den Mittelpunkt

Indeterminate GlobeNewswire

Jun. 14, 2026

KFSH met en avant une IA centrée sur l’humain comme la voie vers de meilleurs soins au HLTH Europe 2026

Indeterminate GlobeNewswire

Jun. 14, 2026

XM Announces Enhanced Trading Conditions and Opportunities for Global Traders - Featuring Partner Code 274PQ

Indeterminate GlobeNewswire